Published in Eur J Neurol on December 01, 2004
Hereditary spastic paraplegia: clinico-pathologic features and emerging molecular mechanisms. Acta Neuropathol (2013) 2.30
Hereditary spastic paraplegias: membrane traffic and the motor pathway. Nat Rev Neurosci (2011) 2.30
Exon deletions of SPG4 are a frequent cause of hereditary spastic paraplegia. J Med Genet (2006) 1.37
Hereditary spastic paraplegia SPG4: what is known and not known about the disease. Brain (2015) 1.28
The Alu-rich genomic architecture of SPAST predisposes to diverse and functionally distinct disease-associated CNV alleles. Am J Hum Genet (2014) 1.14
Spastin mutations are frequent in sporadic spastic paraparesis and their spectrum is different from that observed in familial cases. J Med Genet (2005) 1.01
Diagnosis, investigation and management of hereditary spastic paraplegias in the era of next-generation sequencing. J Neurol (2014) 0.97
A novel mutation in KIF5A gene causing hereditary spastic paraplegia with axonal neuropathy. Neurol Sci (2010) 0.89
Partial SPAST and DPY30 deletions in a Japanese spastic paraplegia type 4 family. Neurogenetics (2010) 0.79
Gray and white matter alterations in hereditary spastic paraplegia type SPG4 and clinical correlations. J Neurol (2015) 0.77
Complex phenotype in an Italian family with a novel mutation in SPG3A. J Neurol (2009) 0.77
Truncating mutations in SPAST patients are associated with a high rate of psychiatric comorbidities in hereditary spastic paraplegia. J Neurol Neurosurg Psychiatry (2017) 0.75
A novel SPAST frameshift mutation in a Chinese family with hereditary spastic paraplegia. Neurol Sci (2016) 0.75
Localization of cystic fibrosis locus to human chromosome 7cen-q22. Nature (1985) 7.77
Cystic fibrosis locus defined by a genetically linked polymorphic DNA marker. Science (1985) 5.81
Long-term follow-up of von Recklinghausen neurofibromatosis. Survival and malignant neoplasms. N Engl J Med (1986) 4.18
The carpal tunnel syndrome: diagnostic utility of the history and physical examination findings. Ann Intern Med (1990) 4.02
Relation between age-related decline in intelligence and cerebral white-matter hyperintensities in healthy octogenarians: a longitudinal study. Lancet (2000) 2.97
Linkage relationships of paraoxonase (PON) with other markers: indication of PON-cystic fibrosis synteny. Clin Genet (1985) 2.96
Opposite base-dependent reactions of a human base excision repair enzyme on DNA containing 7,8-dihydro-8-oxoguanine and abasic sites. EMBO J (1997) 2.65
Production and evaluation of antibodies for the radioimmunoassay of gastrin. Scand J Clin Lab Invest (1972) 2.39
Molecular cloning of human gastrin cDNA: evidence for evolution of gastrin by gene duplication. Proc Natl Acad Sci U S A (1983) 2.35
Regional cerebral blood flow in man determined by the initial slope of the clearance of intra-arterially injected 133Xe. Stroke (1974) 2.26
Determination of gastrin in serum. An evaluation of the reliability of a radioimmunoassay. Scand J Gastroenterol (1973) 2.12
Preparation of 125 I-labelled synthetic human gastrin I for radioimmunoanalysis. Scand J Clin Lab Invest (1972) 2.07
Determination of relative CMRO2 from CBF and BOLD changes: significant increase of oxygen consumption rate during visual stimulation. Magn Reson Med (1999) 2.06
[Back pain--time for a little science?]. Ugeskr Laeger (1998) 2.02
[Molecular biology]. Ugeskr Laeger (2000) 2.02
Quantitation of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors. Magn Reson Med (1990) 1.99
Immunochemical studies on cholecystokinin. II. Distribution and molecular heterogeneity in the central nervous system and small intestine of man and hog. J Biol Chem (1978) 1.99
Gel filtration studies on immunoreactive gastrin in serum from Zollinger-Ellison patients. Gut (1973) 1.97
Evidence of cardiac ischemia during seizures in drug refractory epilepsy patients. Neurology (2003) 1.95
Persistent resetting of the cerebral oxygen/glucose uptake ratio by brain activation: evidence obtained with the Kety-Schmidt technique. J Cereb Blood Flow Metab (1995) 1.82
Pancreatic somatostatinoma. Clinical features and physiological implications. Lancet (1977) 1.81
Ghrelin stimulates gastric emptying and hunger in normal-weight humans. J Clin Endocrinol Metab (2006) 1.81
Does the release of potassium from astrocyte endfeet regulate cerebral blood flow? Science (1987) 1.81
Increased cardiac BNP expression associated with myocardial ischemia. FASEB J (2003) 1.78
Essential tremor treated with propranolol: lack of correlation between clinical effect and plasma propranolol levels. Ann Neurol (1981) 1.75
Somatostatin cell processes as pathways for paracrine secretion. Science (1979) 1.69
Corpus callosum atrophy as a predictor of age-related cognitive and motor impairment: a 3-year follow-up of the LADIS study cohort. J Neurol Sci (2011) 1.66
Immunoreactive gastrin components in human serum. Gut (1974) 1.65
Heritability of ECG measurements in adult male twins. J Electrocardiol (1998) 1.64
Cardiac troponin levels following monitored epileptic seizures. Neurology (2003) 1.64
Regional differences in the CBF and BOLD responses to hypercapnia: a combined PET and fMRI study. Neuroimage (2000) 1.64
Vagal, cholinergic regulation of pancreatic polypeptide secretion. J Clin Invest (1978) 1.63
Immunochemical studies on cholecystokinin. I. Development of sequence-specific radioimmunoassays for porcine triacontatriapeptide cholecystokinin. J Biol Chem (1978) 1.62
Generalizable patterns in neuroimaging: how many principal components? Neuroimage (1999) 1.61
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Antiepileptic drugs: metabolism in pregnancy. Clin Pharmacokinet (1979) 1.57
Pancreatic-polypeptide response to food in duodenal-ulcer patients before and after vagotomy. Lancet (1976) 1.56
Partial and whole gene deletion mutations of the GCK and HNF1A genes in maturity-onset diabetes of the young. Diabetologia (2007) 1.52
gamma-Vinyl GABA: a double-blind placebo-controlled trial in partial epilepsy. Ann Neurol (1985) 1.52
Transcranial Doppler is valid for determination of the lower limit of cerebral blood flow autoregulation. Stroke (1994) 1.52
Dominant optic atrophy mapped to chromosome 3q region. II. Clinical and epidemiological aspects. Acta Ophthalmol Scand (1996) 1.50
Crime in Huntington's disease: a study of registered offences among patients, relatives, and controls. J Neurol Neurosurg Psychiatry (1998) 1.49
Localization and molecular heterogeneity of cholecystokinin in the central and peripheral nervous system. Brain Res (1979) 1.49
Making health care safer II: an updated critical analysis of the evidence for patient safety practices. Evid Rep Technol Assess (Full Rep) (2013) 1.49
Regional blood flow in internal carotid distribution during migraine attack. Br Med J (1969) 1.47
Anticipation in familial cavernous angioma: ascertainment bias or genetic cause. Acta Neurol Scand (1998) 1.46
Molecular genetics of nocturnal enuresis: clinical and genetic heterogeneity. Acta Paediatr (1998) 1.45
Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects. Obes Surg (2012) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Mixed endocrine pancreatic tumors producing several peptide hormones. Am J Pathol (1975) 1.41
Blood-brain and blood-spinal cord barrier permeability during the course of experimental allergic encephalomyelitis in the rat. Brain Res (1984) 1.40
Cloned cell lines from a transplantable islet cell tumor are heterogeneous and express cholecystokinin in addition to islet hormones. J Cell Biol (1986) 1.39
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Neuropeptides and neural cell adhesion molecule (NCAM) in CSF from patients with ALS. Acta Neurol Scand (1989) 1.39
[On back training in low back pain]. Ugeskr Laeger (1993) 1.39
New selective Giemsa technique for human chromosomes, Cd staining. Nature (1974) 1.39
[Diagnosis of polyneuropathies]. Ugeskr Laeger (1998) 1.38
[Surgical treatment of epilepsy resistant to drug therapy. A review]. Ugeskr Laeger (1991) 1.38
Expression but incomplete maturation of progastrin in colorectal carcinomas. Gastroenterology (1993) 1.37
Abnormal gastric histology and decreased acid production in cholecystokinin-B/gastrin receptor-deficient mice. Gastroenterology (1997) 1.37
Changes in regional cerebral blood flow during the course of classic migraine attacks. Ann Neurol (1983) 1.36
Epilepsy and pregnancy: lamotrigine as main drug used. Acta Neurol Scand (2004) 1.36
Release of gastrin by epinephrine in man. Gastroenterology (1973) 1.35
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Cloning of a human UDP-N-acetyl-alpha-D-Galactosamine:polypeptide N-acetylgalactosaminyltransferase that complements other GalNAc-transferases in complete O-glycosylation of the MUC1 tandem repeat. J Biol Chem (1998) 1.34
Impaired gastric acid secretion in gastrin-deficient mice. Am J Physiol (1998) 1.33
Cerebral autoregulation. Stroke (1984) 1.33
Decline in intelligence is associated with progression in white matter hyperintensity volume. J Neurol Neurosurg Psychiatry (2005) 1.32
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Regional cerebral blood flow: a comparison of 8-detector and 16-detector instrumentation. J Nucl Med (1969) 1.31
Batten disease (Spielmeyer-Vogt disease, juvenile onset neuronal ceroid-lipofuscinosis) gene (CLN3) maps to human chromosome 16. Genomics (1990) 1.30
Mosses as biomonitors of atmospheric heavy metal deposition: spatial patterns and temporal trends in Europe. Environ Pollut (2010) 1.29
Vigabatrin: no microvacuoles in a human brain. Epilepsy Res (1987) 1.28
Meta-analysis of European placebo controlled studies of vigabatrin in drug resistant epilepsy. Br J Clin Pharmacol (1989) 1.28
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
Correlation between serum gastrin concentration and rat stomach histidine decarboxylase activity. J Physiol (1974) 1.27
Partitioning of plasmid R1. The parA operon is autoregulated by ParR and its transcription is highly stimulated by a downstream activating element. J Mol Biol (1994) 1.25
Effect of acetazolamide on cerebral blood flow and cerebral metabolic rate for oxygen. J Clin Invest (1984) 1.24
Evidence for coexistence of dopamine and CCK in meso-limbic neurones. Nature (1980) 1.24
New consensus features for tyrosine O-sulfation determined by mutational analysis. J Biol Chem (1997) 1.23
Loss of the retinoblastoma protein-related p130 protein in small cell lung carcinoma. Proc Natl Acad Sci U S A (1997) 1.23
Structure of a human gastrin gene. Proc Natl Acad Sci U S A (1984) 1.23
Monkey median nerve repaired by nerve graft or collagen nerve guide tube. J Neurosci (1995) 1.22
Cerebral activation during micturition in normal men. Brain (2000) 1.22
Suppression of rat stomach histidine decarboxylase activity by histamine: H2-receptor-mediated feed-back. J Physiol (1977) 1.20
Capillary circulation in the brain. Cerebrovasc Brain Metab Rev (1992) 1.20
Genetics of paraoxonase. Ann Hum Genet (1981) 1.20
Epidemiology of myasthenia gravis in Denmark. A longitudinal and comprehensive population survey. Arch Neurol (1991) 1.20
Localisation of gastrins to neuro- and adenohypophysis. Nature (1978) 1.19
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
The effects of PaCO2 on regional cerebral blood flow and internal carotid arterial pressure during carotid clamping. Anesthesiology (1971) 1.18
An exclusion map of Marfan syndrome. J Med Genet (1990) 1.18
Cerebral vasomotor paralysis during migraine attack. Arch Neurol (1973) 1.18
Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures. Epilepsia (1996) 1.16